EP2968173
Heterósýklísk efnasambönd og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.3.2014EP published:
14.10.2020EP application number:
14719472.4
EP translation filed:
14.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2027Next due date:
31.3.2027
Title:
HETEROCYCLIC COMPOUNDS AND THEIR USES
Timeline
Today
14.3.2014EP application
14.10.2020EP Publication
14.12.2020Translation submitted
15.1.2021Registration published
13.3.2027Expires
Owner
Name:
Amgen Inc.Address:
1 Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Name:
Cytokinetics, Inc.Address:
280 East Grand Avenue, South San Francisco, CA 94080, US
Inventor
Name:
BI, MingdaAddress:
Simi Valley, CA 93063, US
Name:
KUEHL, RobertAddress:
San Francisco, CA 94133, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361785763 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 31/496, C07D 213/75, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 8.2.2021
Expires: 13.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2022
Expires: 13.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.2.2024
Expires: 13.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.2.2025
Expires: 13.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.3.2026
Expires: 13.3.2027
Payer: Árnason Faktor ehf.